|Invion Limited -- Australia Stock|| |
AUD 0.01 0.00 0.00%
ConsultantWe currently do not have informatin regarding Tom Coogan. This executive tanure with Invion Limited is not currenlty determined.
Executive Since 2012
61 7 3295 0500 http://invion.com.au
The company has return on total asset (ROA)
of (14.65) %
which means that it has lost $14.65 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (44.01) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 1.26 M in total debt with debt to equity ratio (D/E) of 31.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Invion Limited has Current Ratio of 0.55 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Invion Limited, a clinicalstage drug development company, develops treatments for inflammatory diseases in Australia and the United States. Invion Limited (IVX) is traded on Australian Securities Exchange in Australia. It is located in Brisbane, QLD and employs 2 people.